Skip to main navigation Skip to search Skip to main content

Efficacy and Safety of Camrelizumab Plus Rivoceranib and Local Therapy for Hepatocellular Carcinoma With Lung Metastases (CAPLocal) : A Multicentre, Single-Arm,Prospective Cohort Study

Press/Media

Period2026.04.7

Media coverage

1

Media coverage

  • TitleEfficacy and Safety of Camrelizumab Plus Rivoceranib and Local Therapy for Hepatocellular Carcinoma With Lung Metastases (CAPLocal) : A Multicentre, Single-Arm,Prospective Cohort Study
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date26.04.7
    PersonsGye-Mo Yang
View all 1
View less